Premedication for endotracheal intubation in the newborn infant

Area of Science:

• Neonatal Medicine
• Pediatric Anesthesiology
• Clinical Pharmacology

Background:

• Endotracheal intubation in newborns can cause significant pain and cardiorespiratory instability.
• Adverse physiological responses include bradycardia, hypertension, intracranial hypertension, and hypoxia.
• Pain and discomfort are major concerns during neonatal intubation.

Purpose of the Study:

• To establish the importance of analgesic premedication for endotracheal intubation in neonates.
• To recommend an optimal premedication protocol based on current evidence.
• To emphasize the need for trained staff and monitoring during neonatal intubation.

Main Methods:

• Review of current evidence on neonatal endotracheal intubation premedication.
• Identification of effective agents for analgesia, vagolysis, and muscle relaxation.
• Delineation of an optimal drug protocol and dosage recommendations.

Main Results:

• Premedication effectively mitigates adverse physiological responses to intubation.
• Premedication significantly reduces pain and discomfort for neonates.
• An optimal protocol involves IV atropine (20 μg/kg), IV fentanyl (3–5 μg/kg), and IV succinylcholine (2 mg/kg).

Conclusions:

• Analgesic premedication should be administered to all neonates undergoing endotracheal intubation, barring emergencies.
• The recommended protocol optimizes safety and comfort during the procedure.
• Trained personnel and vigilant monitoring are crucial for successful and safe intubation.